IceCure Medical Ltd. ICCM
1.73
0.00
0.00%
as of 25 Sep
- Market cap
- $6.5M
- P/E
- 0.0×
Follow ICCM
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | (212.37%) | 0.00% | 0.00% |
+8 more TTM periods Free account |
|
| 0.00% | (126.11%) | 0.00% | 0.00% | ||
ROIC |
0.00% | (2,524.58%) | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | (185.54%) | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 37.05 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (8.48) | — | 0.00 | |
Free Cash Flow |
(20.63) | (20.78) | — | (24.84) | |
Capital Expenditures |
(0.11) | (0.11) | — | (0.06) | |
Piotroski F-Score |
— | 2.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(85.65%) | (124.44%) | 0.00% | (128.12%) | |
Accounts Receivable Turnover |
0.00 | 9.41 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 2.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.83 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 185.89 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 497.84 | 0.00 | 0.00 | |
Tax Rate |
— | 0.00 | — | — | |
Research and Development Expense of Revenue |
— | 295.68% | — | — | |
Selling, General and Administrative Expense of Revenue |
— | 310.13% | — | — | |
Share Based Compensation of Revenue |
0.00% | 58.42% | — | 0.00% | |
Interest Coverage |
— | 0.00 | — | — | |
Operating CF/Net income |
0.00 | 1.34 | — | 0.00 | |
Depreciation/Fixed assets |
0.47 | 0.46 | 0.00 | 0.59 | |
Capex/Depreciation |
(0.27) | (0.25) | — | (0.10) | |
Revenue per Share |
— | 1.10 | — | — | |
Operating CF per Share |
0.00 | (8.44) | — | 0.00 | |
Capex per Share |
0.00 | (0.04) | — | 0.00 | |
Capex to Sales |
0.00 | 0.04 | — | 0.00 | |
Net Profit Margin |
— | (570.14%) | — | — |
Columns are period end dates